Aims: To describe the auditory and language outcomes of children with early diagnosis and treatment for congenital toxoplasmosis. Methods: A cross-sectional study included all children diagnosed with congenital toxoplasmosis, through the Minas Gerais State Neonatal Screening Program, from September 2006 to March 2007. All children received early treatment, initiated before the age of 2.5 months, and were periodically assisted by a team of specialists including pediatricians, ophthalmologists and speech-language therapists and audiologists. Hearing function was evaluated with the following procedures: tympanometry, transient evoked otoacoustic emissions, distortion product otoacoustic emissions, behavioral observation audiometry, and brainstem auditory evoked potentials. Hearing function and sensitivity was estimated and audiological results were classified as normal, conductive hearing loss, sensoryneural hearing loss and central dysfunction. Language performance was assessed and classified as normal or abnormal, according to test results. The following variables were studied: audiological results, neurological and ophthalmological conditions, language performance and presence of risk indicator for hearing loss other than congenital toxoplasmosis. Univariate analysis was conducted using the chi-square or Fisher's Exact test. Results: From September 2006 to March 2007, 106 children were diagnosed with congenital toxoplasmosis through the neonatal screening program, and were included in the study. Data analysis showed normal hearing in 60 children (56.6%), while 13 children (12.3%) had conductive hearing loss, four children (3.8%) had sensory-neural hearing loss and 29 children (27.4%) presented central hearing dysfunction. There was association between hearing problems and language deficits. The comparison between children with additional risks for hearing loss other than toxoplasmosis and children who only presented toxoplasmosis as a risk factor showed no differences. This finding suggests that audiological problems were due to congenital toxoplasmosis alone. Conclusions: Even with early diagnosis and treatment, a high prevalence of hearing problems and language delays was observed in children with congenital toxoplasmosis.
Purpose: To investigate the correlation between risk indicators and hearing impairment in infants of a Newborn hearing screening program Methods: A retrospective study with 3151 newborn records with and without risk indicator for hearing loss, followed-up by a Newborn hearing screening program at a Public Hospital in the city of Belo Horizonte (MG). Results: In the group without risk indicators, the incidence of hearing loss was 1.04%: 0.04% were sensorineural and 0.99% were conductive. In the group with risk indicators, the incidence of hearing loss was 8.38% (5.27% conductive and 3.1% sensorineural). In the high risk group one child (0.33%), who passed the screening, was diagnosed during the follow up with bilateral sensorineural mild hearing. The most common risk indicators were neonatal intensive care of >5 days (43.47%) followed by use of ototoxic drugs, (29.81%) and mechanical ventilation (28.88%). It was observed that children with suspected syndromes have 18 times more chance of acquiring sensorineural hearing loss. Conclusion: The risk indicator which correlated to hearing loss was suspicion of syndromes. Health promotion actions are necessary to reduce the presence of risk indicators found in the served population.
Combined cervical and ocular vestibular evoked myogenic potential presented relevant results for individuals with vestibular hyporeflexia and for those with Ménière's disease. There were differences between the study groups and the control group for most of the wave parameters in combined cervical and ocular vestibular evoked myogenic potential.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.